08:00 Registration opens
09:00 Opening remarks
Morning session: Formulation and drug-device development – the present and the future
09:15 Moving from Drug Delivery towards Patient Outcome improvement: a serious challenge for Biologic Formulation Technology
Didier Pertuy (VP, Global Head Drug-Device Development, Sanofi, France)
09:45 Cell and gene therapy formulation technologies: transitioning clinical therapies to medicines
Rita Majithiya (Investigator, Formulation and delivery, GSK, UK)
10:15 Speed Networking
11:15 Producing protein and structures for human membrane proteins for antibody development and drug design
Liz Carpenter (Professor, University of Oxford, UK)
11:45 Exhibitors highlight
12:40 Lunch Break, Exhibition and Posters
Afternoon session: Creative formulation approaches to overcome new and old challenges
13:45 Introduction
14:00 Development of co-formulation of monoclonal antibodies and recombinant human hyaluronidase (rHuPH20) - a case study
Astrid Pappenberger (Group leader, Senior Scientist, Roche, Switzerland)
14:30 Combining computational approaches and experiments for selecting compounds with the desired properties, applied in particular to the osmolyte-like effects on the thermal stability of a monoclonal antibody
Andreas Bender (Lecturer for molecular informatics and drug design, University of Cambridge, UK)
15:00 Coffee break, Exhibition and Posters
15:30 Use of Math Modelling to Understand Delivery of Biopharmaceuticals to the Lung
Nia Stevens (Investigator, GSK, UK)
16:00 Discussion panel:
Creative formulation to enable new product concepts – Current and future trends, regulatory considerations and alignment with product strategies
17:00 Concluding remarks
17:10 Conference ends